NuCana plc (NCNA) Financials

NCNA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 41.4 million 14.9 million
2023-06-30 52.1 million 17.5 million
2023-03-31 72.2 million 24.5 million
2022-12-31 70.5 million 23.9 million

NCNA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -12.5 million 1.1 million
2023-06-30 -7.6 million 1.3 million
2023-03-31 -8.5 million 1.2 million
2022-12-31 -8.3 million 1.2 million

NCNA Net Income

No data available :(

NCNA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 21.7 million - 551304
2023-06-30 31.1 million - 713286
2023-03-31 51.9 million - 745884
2022-12-31 50.7 million - 773281

NCNA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 64.2 million
2023-06-30 66.1 million
2023-03-31 64.9 million
2022-12-31 63.4 million

NCNA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 103674 9.1 million 1.7 million -
2023-06-30 172956 5.0 million 2.2 million -
2023-03-31 136291 16.3 million 1.9 million -
2022-12-31 133115 16.0 million 1.9 million -

NCNA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 - -
2023-03-31 - -
2022-12-31 - -

NCNA

Price: $4

52 week price:
0.18
4.03

Earnings Per Share: -0.67 USD

P/E Ratio: -0.33

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 46300

Market Capitalization: 12.5 million

Links: